Showing results (231-240 of 377) with videos related to
Sort By:
Pageof 38
Cancer|July 23, 2016
Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance)Jeanne S Mandelblatt, Jonathan D Clapp, Gheorghe Luta, et al.Journal of the National Cancer Institute|February 3, 2012
Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examinationJoel L Weissfeld, Robert E Schoen, Paul F Pinsky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2020
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)Nadine Tung, Banu Arun, Michele R Hacker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2008
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective studyNoah D Kauff, Susan M Domchek, Tara M Friebel, et al.Breast Cancer Research and Treatment|February 25, 2010
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriersSusan M Domchek, Tara M Friebel, Judy E Garber, et al.Nature Biotechnology|February 5, 2025
Implantation of engineered adipocytes suppresses tumor progression in cancer modelsHai P Nguyen, Kelly An, Yusuke Ito, et al.The New England Journal of Medicine|April 21, 2021
Sacituzumab Govitecan in Metastatic Triple-Negative Breast CancerAditya Bardia, Sara A Hurvitz, Sara M Tolaney, et al.Breast Cancer Research and Treatment|December 7, 2024
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancerVishnu Prasath, Hinda Boutrid, Robert Wesolowski, et al.Biorxiv : the Preprint Server for Biology|May 20, 2024
Clinicogenomic characterization of inflammatory breast cancerNolan Priedigkeit, Beth Harrison, Robert Shue, et al.Journal of the National Cancer Institute|May 6, 2010
Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialWilliam G Hocking, Ping Hu, Martin M Oken, et al.Pageof 38